EUVIMEDEUVIMED entdecken
Crossref

Network Pharmacology Analysis and Screening of Key Active Components in NuanXin Formula for Inhibiting Osteoclast Differentiation in Osteoporosis

Baichuan ZHANG, Wenqing XIA, Delong SONG, Fujun JIN

Advances in Traditional Chinese Medicine · 2026

DOI: 10.48014/atcm.20260702001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Traditional Chinese Medicine, 2026. Verfasst von Baichuan ZHANG und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To screen the key active components of NuanXin Formula (NX) that inhibit osteoclast (OCs) differentiation and exert anti-osteoporosis (OP) effects, and to evaluate their inhibitory effects on OCs differentiation in vitro.

Methods

Liquid chromatography-mass spectrometry (LC-MS) combined with network pharmacology was employed to identify and screen potential active components of NX. An OCs differentiation model was established by inducing RAW264. 7 cells with the receptor activator of nuclear factor-κB ligand (RANKL) . The CCK-8 assay was performed to assess the effects of NX extract and individual monomeric components on the viability of RAW264. 7 cells. Tartrate-resistant acid phosphatase (TRAP) staining and activity assays were utilized to evaluate the impact of NX extract and its key active components on OCs differentiation.

Results

LC-MS analysis identified 277 compounds in NX. Network pharmacology analysis revealed that four compounds—Osthole, 5, 7-Dihydroxy-4-methylcoumarin (D4M) , Lauric acid, and 1, 8-Cineole—were closely associated with OP-related targets. Cellular experiments showed that NX extract (0. 5-8mg/mL) inhibited RANKL-induced OCs differentiation in a dose-dependent manner (P

Zitieren

APA

ZHANG, B., XIA, W., SONG, D., & JIN, F. (2026). Network Pharmacology Analysis and Screening of Key Active Components in NuanXin Formula for Inhibiting Osteoclast Differentiation in Osteoporosis. Advances in Traditional Chinese Medicine. https://doi.org/10.48014/atcm.20260702001

Vancouver

ZHANG B, XIA W, SONG D, JIN F. Network Pharmacology Analysis and Screening of Key Active Components in NuanXin Formula for Inhibiting Osteoclast Differentiation in Osteoporosis. Advances in Traditional Chinese Medicine. 2026. doi:10.48014/atcm.20260702001

BibTeX
@article{ZHANG2026,
  author = {ZHANG, Baichuan and XIA, Wenqing and SONG, Delong and JIN, Fujun},
  title = {Network Pharmacology Analysis and Screening of Key Active Components in NuanXin Formula for Inhibiting Osteoclast Differentiation in Osteoporosis},
  journal = {Advances in Traditional Chinese Medicine},
  year = {2026},
  doi = {10.48014/atcm.20260702001}
}
Kostenlos starten →